Print
Email
Bookmark
RSS
Research Puts A 'Fas' To The Cause Of Programmed Cell Death
Researchers have put an end
to a 10-year debate over
which form of a molecular
messenger called Fas ligand
is responsible for killing
cells during programmed cell
... > full story
First Evidence Of Virus In Malignant Prostate Cells: XMRV Retrovirus Linked To More Aggressive Tumors
In a finding with
potentially major
implications for identifying
a viral cause of prostate
cancer, researchers have
... > full story
Protein Complex Key In Avoiding DNA Repair Mistakes, Cancer
Lymphoma and other cancers
may occur when a delicate
gene recombination process
in antibody-making cells
goes awry, according to
preliminary studies in mice
... > full story
How Cancers Spread To The Brain
Research has shown for the
first time how cancers that
spread to the brain
establish themselves and
begin to grow. ... > full story
Browse News Stories
1 to 10 of 452 stories (90 over past year)
view headlines only
-
New Way To Attack Inflammation In Graves' Eye Disease
November 7, 2009 — A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms -- and improved vision -- following treatment with the drug rituximab. Inflammation around ... > full story -
Exercise Is Good Medicine For Lymphoma Patients
November 7, 2009 — A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have ... > full story -
First Use Of Antibody And Stem Cell Transplantation To Successfully Treat Advanced Leukemia
November 6, 2009 — For the first time, researchers have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia ... > full story -
Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer
November 5, 2009 — A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage ... > full story -
Immunotherapy Demonstrates Long-term Success In Treating Lymphoma
November 2, 2009 — Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study ... > full story -
Radiation After Surgery Reduces Chance Of Melanoma Returning
November 2, 2009 — High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do ... > full story -
Additional, Specialized Radiation Not Necessary For Some Women After Mastectomy
November 2, 2009 — After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this ... > full story -
Helper T Cell's Effect Raises Possibility Of Cellular Therapy, Vaccine Development
October 30, 2009 — A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists ... > full story -
Do Drug Therapies Raise Risk Of Bladder Cancer?
October 27, 2009 — In a recent study of possible triggers of cancer among northern New England residents, epidemiologists identified an enhanced risk to the bladders of patients taking drugs that suppress the immune ... > full story -
Study Shows How Normal Cells Influence Tumor Growth
October 21, 2009 — A new study by cancer researchers shows for the first time that the loss of a gene called PTEN from a type of normal cell in breast tumors can dramatically change the environment within the tumor in ... > full story
Search ScienceDaily
Number of stories in archives: 77,255
